Shi-Rong Zhang
Overview
Explore the profile of Shi-Rong Zhang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
575
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Zhang S, Li H, Wang W, Jin W, Xu J, Xu H, et al.
Eur J Surg Oncol
. 2018 Nov;
45(5):769-775.
PMID: 30416079
Introduction: Arpin (Arp2/3 complex inhibitor), a novel protein found in 2013, plays a pivotal role in cell motility and migration. However, the prognostic value of Arpin in pancreatic ductal adenocarcinoma...
12.
Jin W, Xu H, Zhang S, Li H, Wang W, Gao H, et al.
Ann Surg Oncol
. 2018 Oct;
26(2):635-643.
PMID: 30374923
Background: Tumor-infiltrating neutrophils (TINs) indicate poor prognosis for patients with pancreatic ductal adenocarcinoma (PDAC). Activated neutrophils can generate neutrophil extracellular traps (NETs). Little is known about the presence and prognostic...
13.
Zhang S, Li H, Wang W, Liu L, Yu X
Ann Surg Oncol
. 2018 Oct;
25(13):3994-3995.
PMID: 30315385
No abstract available.
14.
Qi Z, Xu H, Zhang S, Xu J, Li S, Gao H, et al.
J Cancer
. 2018 Oct;
9(18):3417-3426.
PMID: 30271504
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal types of cancer. The 5-year survival rate for PDAC remains low because it is always diagnosed at an advanced stage...
15.
Zhang S, Yao L, Wang W, Xu J, Xu H, Jin W, et al.
Ann Surg Oncol
. 2018 Sep;
25(13):3984-3993.
PMID: 30171511
Background: Platelets are believed to promote tumor growth and metastasis in several tumor types. The prognostic role of blood platelets in pancreatic ductal adenocarcinoma (PDAC) remains controversial, and the prognostic...
16.
Li S, Xu H, Wu C, Wang W, Jin W, Gao H, et al.
Angiogenesis
. 2018 Sep;
22(1):15-36.
PMID: 30168025
Pancreatic cancer is one of the most lethal malignancies worldwide. Although the standard of care in pancreatic cancer has improved, prognoses for patients remain poor with a 5-year survival rate...
17.
Xu H, Li S, Wu C, Qi Z, Wang W, Jin W, et al.
Pancreatology
. 2018 Aug;
18(6):671-677.
PMID: 30153903
Objective: To evaluate the prediction of benefits from adjuvant chemoradiotherapy by postoperative serum CA19-9, CA125 and CEA. Methods: The relations between benefits from adjuvant chemoradiotherapy and levels of postoperative serum...
18.
Zhao Y, Wu Q, Wu Z, Zhang J, Zhu L, Yang Y, et al.
Int J Oncol
. 2018 Jun;
53(2):539-550.
PMID: 29901106
Post-operative microwave (MW) hyperthermia has been applied as an important adjuvant therapy to enhance the efficacy of traditional cancer treatment. A better understanding of the molecular mechanisms of MW hyperthermia...
19.
Xu J, Wang W, Zhang S, Xu H, Wu C, Qi Z, et al.
Curr Med Chem
. 2018 Apr;
26(40):7196-7211.
PMID: 29651946
Background: Awareness of the benefits of neoadjuvant therapy is increasing, but its use as an initial therapeutic option for patients with resectable pancreatic cancer remains controversial, especially for those patients...
20.
Gao H, Liu L, Qi Z, Xu H, Wang W, Wu C, et al.
Hepatobiliary Pancreat Dis Int
. 2018 Mar;
17(2):95-100.
PMID: 29576277
Background: Immunotherapy has shown promise against solid tumors. However, the clinical significance of programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) in pancreatic ductal adenocarcinoma (PDAC)...